Clinical Trial Update: Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial of liposomal daunorubicin for HIV-related Kaposi's sarcoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• DaunoXome (liposomal daunorubicin) (liposomal daunorubicin)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Sarcoma | Phase 1 | Status: TERMINATED